The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers
about
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
The therapeutic ratio is prese ...... BRCA2-mutated prostate cancers
@ast
The therapeutic ratio is prese ...... BRCA2-mutated prostate cancers
@en
type
label
The therapeutic ratio is prese ...... BRCA2-mutated prostate cancers
@ast
The therapeutic ratio is prese ...... BRCA2-mutated prostate cancers
@en
prefLabel
The therapeutic ratio is prese ...... BRCA2-mutated prostate cancers
@ast
The therapeutic ratio is prese ...... BRCA2-mutated prostate cancers
@en
P2093
P2860
P356
P1476
The therapeutic ratio is prese ...... BRCA2-mutated prostate cancers
@en
P2093
Danny Vesprini
Farid Jalali
John Preiner
John Trachtenberg
Juanita Crook
Srikala Sridhar
Steven A Narod
P2860
P356
10.5489/CUAJ.10080
P577
2011-04-01T00:00:00Z